Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 7, 2017Experimental DermatologyOpen Access

Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

Emma Guttman‐Yassky
Emma Guttman‐YasskyUniversity of Copenhagen
James G. Krueger
James G. KruegerRutgers, The State University of New Jersey
Mark Lebwohl
Mark LebwohlUniversity of Hawaiʻi at Mānoa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Guttman‐Yassky et al. (2017) studied this question.

synapsesocial.com/papers/69d8f99c6715230d10bede4chttps://doi.org/10.1111/exd.13336
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema2006 · 481 citations
  2. 2Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis2005 · 341 citations
  3. 3The Association Between Atopy and Childhood/Adolescent Leukemia: A Meta-Analysis2010 · 89 citations
  4. 4IL‐31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis2012 · 161 citations